Arcutis Biotherapeutics has published 14 consensus statements developed by the Genital Psoriasis Wellness Consortium, a group of experts aimed at improving the understanding and management of genital ...

Dr. Joshua K. Sabari sat down with Dr. Daniel V. Araujo to discuss topline takeaways from the 2025 ASCO Meeting across the realm of genitourinary oncology Dr. Joshua K. Sabari sat down with Dr. Daniel ...

The AMPLITUDE trial showed Zejula's efficacy in extending progression-free survival in metastatic hormone-sensitive prostate cancer with HRR gene defects. Achieving a PSA level below 0.2 in prostate ...

Arcutis convened the Genital Psoriasis Wellness Consortium, a multidisciplinary group of clinicians who are experts in their fields Publication includes 14 consensus statements aimed at improving ...

An indirect treatment comparison (ITC) and cost-effectiveness analysis of abiraterone acetate and enzalutamide for the treatment of metastatic castration-resistant prostate cancer (mCRPC) ...

Standardized Patients (SP) are "Individuals who are trained to present the symptoms and signs of disease process as they present in real patients" (Barrows, 1985). Standardized patients have been ...

In an online survey, 17.2% of patients with genitourinary cancers reported they delayed or avoided seeking medical care because of the COVID-19 pandemic. Preliminary survey findings presented at the ...